S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

DexCom (DXCM) SEC Filings & 10K Form

$134.30
+0.44 (+0.33%)
(As of 04/18/2024 ET)

Recent DexCom SEC Filings

DateFilerForm TypeView
04/16/2024
3:16 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:04 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
5:22 PM
DexCom (Subject)
Naganathan Girish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:30 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:33 PM
Brown Michael Jon (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2024
3:46 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
3:08 PM
Abbey Donald (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:09 PM
DexCom (Subject)
Flynn Paul R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
3:10 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2024
3:55 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:37 PM
DexCom (Subject)
Dolan Matthew Vincent (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
3:39 PM
DexCom (Subject)
Flynn Paul R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
4:39 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:39 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:39 PM
DexCom (Issuer)
Lawver Teri L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:40 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:30 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:30 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:31 PM
DexCom (Issuer)
Lawver Teri L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:31 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:31 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:32 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:32 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
4:31 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
4:48 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:15 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
4:14 PM
DexCom (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/17/2024
5:54 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
5:56 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
5:47 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
5:49 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
5:49 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
7:02 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
3:35 PM
DexCom (Issuer)
Regan Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:36 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:36 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:37 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
3:37 PM
DexCom (Issuer)
Flynn Paul R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report (Ad)

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

[Get Your Insights Now]
12/18/2023
3:31 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:32 PM
AUGUSTINOS NICHOLAS (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
4:26 PM
AUGUSTINOS NICHOLAS (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2023
9:19 AM
ALTMAN STEVEN R (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
3:18 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
5:15 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
3:26 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
5:10 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:08 PM
Brown Michael Jon (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
6:34 PM
DexCom (Issuer)
Naganathan Girish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
2:51 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2023
12:10 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2023
3:23 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
6:26 PM
DexCom (Issuer)
Regan Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
6:27 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
5:36 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
3:19 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2023
4:14 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2023
6:43 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
3:46 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2023
3:15 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
5:30 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:15 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2023
3:43 PM
ALTMAN STEVEN R (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
9:51 AM
ALTMAN STEVEN R (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
6:55 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
12:58 PM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
5:40 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2023
10:55 AM
DexCom (Issuer)
Driscoll Rimma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2023
7:41 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2023
4:42 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:14 PM
DexCom (Subject)
Sylvain Jereme M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
2:59 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/27/2023
4:08 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2023
4:18 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:17 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2023
3:54 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2023
4:58 PM
Balo Andrew K (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2023
3:09 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
4:39 PM
DexCom (Issuer)
Regan Barry J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
4:40 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:57 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
3:43 PM
DexCom (Subject)
Regan Barry J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2023
3:16 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:41 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
7:15 PM
Balo Andrew K (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
6:04 PM
DexCom (Subject)
Selvaraj Shelly Ramasamy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2023
4:16 PM
DexCom (Issuer)
Selvaraj Shelly Ramasamy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
7:13 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/23/2023
6:12 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Healthcare Takes A Big Step Forward With The Help Of AI (Ad)

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic
05/23/2023
6:13 PM
DexCom (Issuer)
Pacelli Steven Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
3:45 PM
DexCom (Subject)
Pacelli Steven Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2023
2:45 PM
Dahut Karen M (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
2:47 PM
DexCom (Issuer)
TOPOL ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
2:47 PM
DexCom (Issuer)
Malady Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
2:48 PM
DexCom (Issuer)
KAHN BARBARA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
2:48 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
2:49 PM
DexCom (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
2:49 PM
Collins Richard Alexander (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DXCM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners